CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 185 filers reported holding CYTOKINETICS INC in Q4 2020. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,029,401 | +2.3% | 204,664 | +13.2% | 0.18% | +12.5% |
| Q2 2023 | $5,895,347 | -16.0% | 180,728 | -9.4% | 0.16% | -21.2% |
| Q1 2023 | $7,017,449 | +95531.6% | 199,416 | +24.5% | 0.20% | -11.7% |
| Q4 2022 | $7,338 | -99.9% | 160,143 | +7.6% | 0.23% | -1.7% |
| Q3 2022 | $7,211,000 | +5.2% | 148,834 | -14.7% | 0.23% | +13.0% |
| Q2 2022 | $6,856,000 | -15.2% | 174,493 | -20.5% | 0.21% | +8.4% |
| Q1 2022 | $8,081,000 | -18.1% | 219,540 | +1.5% | 0.19% | -3.5% |
| Q4 2021 | $9,863,000 | -4.3% | 216,380 | -25.0% | 0.20% | -7.5% |
| Q3 2021 | $10,311,000 | +22.8% | 288,496 | -32.0% | 0.21% | +41.7% |
| Q2 2021 | $8,394,000 | -19.2% | 424,175 | -5.0% | 0.15% | -21.8% |
| Q1 2021 | $10,387,000 | -10.0% | 446,554 | -19.6% | 0.19% | -12.3% |
| Q4 2020 | $11,547,000 | – | 555,684 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |